Two Phase I/II , randomized , controlled studies were conducted to compare the immunogenicity and safety of investigational tetravalent HPV L@ virus-like particle ( VLP ) vaccines , containing VLPs from two additional oncogenic genotypes , with the licensed HPV-@ / @ AS@-adjuvanted vaccine ( control ) in healthy @-@ year-old women .